Survival and long-term quality-of-life of concurrent chemoradiotherapy versus surgery followed by radiotherapy with or without concurrent chemotherapy for the treatment of resectable stage III/IV hypopharyngeal carcinoma.

Asian journal of surgery(2023)

引用 1|浏览13
暂无评分
摘要
For resectable stage III/IV HPSCC patients, appropriate treatment plans should be selected comprehensively considering survival rate, QOL, patient preference and multidisciplinary treatment.
更多
查看译文
关键词
Hypopharyngeal carcinoma,Surgery,Concurrent chemoradiotherapy,Survival,Quality-of-life
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要